Why the study?
Is catheter ablation cost-effective in symptomatic patients with atrial fibrillation non-responsive to antiarrhythmic drugs?
Is catheter ablation cost-effective in symptomatic patients with atrial fibrillation non-responsive to antiarrhythmic drugs?
Catheter ablation is most likely cost-effective in patients with paroxysmal AF refractory to antiarrhythmic drugs who experience long-term quality of life improvements.
No takes yet. Share an insight, caveat, or question.
May support selective ablation in refractory paroxysmal AF with durable QoL gains; leaves open need for long-term prospective cost-effectiveness trials.
Kautzner et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: